0.6029

22.82% 0.112

Applied Therapeutics Inc (APLT)

Overview News Price History Option Chain Financials Discussions Forecast

Applied Therapeutics Inc stock is traded at $0.6029, with a volume of 7.66M. It is up +22.82% in the last 24 hours and up +98.45% over the past month. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Previous Close:

$0.4909

Open:

$0.5

24h Volume:

7.66M

Relative Volume:

3.42

Market Cap:

$85.36M

Revenue:

Net Income/Loss:

$-119.76M

P/E Ratio:

-0.4466

EPS:

-1.35

Net Cash Flow:

$-55.17M

1W Performance:

+50.84%

1M Performance:

+98.45%

6M Performance:

-93.06%

1Y Performance:

-85.81%

1-Day Range:

$0.491

$0.638

1-Week Range:

$0.4151

$0.638

52-Week Range:

$0.295

$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name

Applied Therapeutics Inc

Sector

Healthcare (1170)

Industry

Biotechnology (671)

Phone

212-220-9226

Address

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Employee

Twitter

@Applied_Tx

Next Earnings Date

2025-03-31

Latest SEC Filings

APLT's Discussions on Twitter

Compare APLT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
APLT Applied Therapeutics Inc	0.6029	56.59M	0	-119.76M	-55.17M	-1.35
ONC Beigene Ltd Adr	228.38	25.07B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	438.65	109.14B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.27	36.39M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	594.32	56.98B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	71.31	5.39B	0	-153.72M	-103.81M	-2.00

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-23-24	Downgrade	William Blair	Outperform → Mkt Perform
Dec-02-24	Downgrade	UBS	Buy → Neutral
Nov-29-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-31-24	Initiated	William Blair	Outperform
Mar-26-24	Initiated	RBC Capital Mkts	Outperform
Feb-22-24	Initiated	Leerink Partners	Outperform
Jan-04-22	Downgrade	Barclays	Overweight → Equal Weight
Aug-27-21	Downgrade	Goldman	Neutral → Sell
Jun-25-21	Resumed	Goldman	Neutral
Oct-08-20	Initiated	Truist	Buy
Apr-22-20	Initiated	Goldman	Buy
Feb-27-20	Initiated	Barclays	Overweight
Jun-10-19	Initiated	Citigroup	Buy
Jun-10-19	Initiated	Cowen	Outperform
Jun-10-19	Initiated	Robert W. Baird	Outperform

View All

Applied Therapeutics Inc Stock (APLT) Latest News

May 14, 2025

APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus

May 14, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus

May 14, 2025

Applied Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 14, 2025

May 13, 2025

APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus

May 13, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - Bluefield Daily Telegraph

May 13, 2025

Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.

May 13, 2025

May 12, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

May 12, 2025

Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 12, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire

May 12, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT - ACCESS Newswire

May 12, 2025

May 11, 2025

Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire

May 11, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 11, 2025

Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - ACCESS Newswire

May 11, 2025

Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

May 11, 2025

May 10, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire

May 10, 2025

Applied Therapeutics Announces Acceptance of Late-Breaking Abstr - GuruFocus

May 10, 2025

May 09, 2025